Cancer Research UK turns to gamification with app
February 4, 2014Medical Communications, Sales and Marketing CRUK, Cancer, Gamification, genes in space
Cancer Research UK has launched a new citizen science game aimed at helping its scientists discover new cures for cancer. …
New Ashfield unit to meet pharma’s challenges
February 4, 2014Medical Communications ashfield healthcare
Ashfield healthcare has created a new division to integrate its eight units into one business area offering in an effort …
Pfizer breast cancer drug shows promise
February 4, 2014Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial. The pill was administered …
Biogen Idec’s MS drug gets European approval
February 4, 2014Manufacturing and Production, Sales and Marketing Aubagio, Biogen IDEC, EU, MS, gilenya, tecdifera
Biogen Idec’s oral multiple sclerosis drug Tecfidera has won approval in Europe as a first-line treatment for people with relapsing-remitting …
AstraZeneca ‘simplifies decision-making’
February 4, 2014Sales and Marketing AstraZeneca, BMS, Byetta, Forxiga, Onglyza, diabetes
AstraZeneca has completed its $4.3 billion acquisition of Bristol-Myers Squibb’s diabetes business, giving the company control over several big-name brands …
Sir Michael Parkinson criticises NICE
February 4, 2014Medical Communications, Sales and Marketing Astellas, NHS, NICE, Xtandi, parkinson, prostate
TV host Sir Michael Parkinson has told NICE that it must lift the restrictions imposed on Astellas’ new prostate cancer …
Sartorius hires laboratory manager
February 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michael Melingo, satorius
Lab and technology firm Sartorius has appointed Michael Melingo to be its laboratory manager. Melingo is to succeed Dominique Baly …
Roche: NICE guidance ‘perverse’
February 4, 2014Sales and Marketing NHS, NICE, NSCLC, Roche, Tarceva
Roche has poured scorn on NICE’s ‘perverse’ recommendation that its EGFR-TK inhibitor Tarceva should no longer be given to NHS …
J&J reveals more on transparency policy
February 3, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda
Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …
AbbVie ‘pleased’ with first year
February 3, 2014Sales and Marketing AbbVie, Abbott, CLL, EMA, HIV, Humira
Rheumatoid arthritis treatment Humira – as expected – has driven AbbVie in its first year as a standalone company, accounting …
Scotland reforms will see drug access improve
February 3, 2014Sales and Marketing PACE, SMC, Scotland, drugs, neil
Scotland is set to overhaul its medicines access system after complaints from charities and interest groups that patients have been …
Teva/VCCP on top at PM Society ad awards
February 3, 2014Medical Communications, Sales and Marketing 2014, Teva, ads, advertising, neil smith, pm awards, vccp
Teva and its agency partner VCCP took home the most wins from this year’s PM Society Advertising Awards that featured …
Cancer Drugs Fund: assessing a difficult legacy
February 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty
England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …
Novo Nordisk makes Eddie Williams senior VP
February 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, eddie williams
Novo Nordisk has promoted Eddie Williams to the position of senior vice president of its biopharmaceuticals unit. Williams brings three …
Sanofi files Lilly lawsuit
February 3, 2014Sales and Marketing FDA, Lantus, Sanofi, lilly
A row which has been brewing between Sanofi and Eli Lilly & Company has now erupted with the French manufacturer …
UK invests in Oxford bioscience site
January 31, 2014Research and Development, Sales and Marketing Milton Park, Oxford, UK, bioscience, government
The government is putting £7 million into Milton Park, near Oxford, to boost the building of a new laboratory and …
Nintendo plans new healthcare venture
January 31, 2014Medical Communications, Sales and Marketing digital, games, healthcare, nintendo, wii
Console giant Nintendo has confirmed that it is about to set up a new healthcare business separate from its entertainment …
Metamark names new chief commercial officer
January 31, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cornelius, metamark
US Biotech firm Metamark Genetics has named the former general manager of HealthTronics Laboratory Solutions Cornelius Merlini, as its senior …
Lilly to go ‘on offense’
January 31, 2014Sales and Marketing Alimta, Lechleiter, cymbalta, lilly, q4, zyprexa
The loss of patent on antidepressant Cymbalta in the US last December was largely responsible for Eli Lilly & Co’s …
Oncology drives Roche profits
January 30, 2014Sales and Marketing Actemra, Perjeta, Roche, Swiss, q4
Sales at Roche’s pharma division rose 7% year-on-year in 2013, driven largely by strong performances from its oncology portfolio. Group …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
